Fig. 3From: Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarctionKaplan–Meier curves for MACE during the 12-month follow-up of patients in the ICP and ICPpD groups. Log-rank test, P = 0.039. MACE major adverse cardiovascular events, including cardiac death, reinfarction, heart failure, and strokeBack to article page